Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study
Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery dis...
Saved in:
Published in | Journal of the American College of Cardiology Vol. 73; no. 3; pp. 291 - 301 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
29.01.2019
Elsevier Limited Elsevier Biomedical |
Subjects | |
Online Access | Get full text |
ISSN | 0735-1097 1558-3597 1558-3597 |
DOI | 10.1016/j.jacc.2018.10.066 |
Cover
Loading…
Abstract | Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.
The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease.
In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years.
Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden.
Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590)
[Display omitted] |
---|---|
AbstractList | Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.BACKGROUNDUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease.OBJECTIVESThe purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease.In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years.METHODSIn this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years.Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden.RESULTSAmong study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden.Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590).CONCLUSIONSAdverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590). Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease. In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years. Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden. Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590) [Display omitted] BackgroundUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.ObjectivesThe purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease.MethodsIn this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years.ResultsAmong study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden.ConclusionsAdverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590) AbstractBackgroundUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. ObjectivesThe purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease. MethodsIn this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years. ResultsAmong study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden. ConclusionsAdverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590) Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease. In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years. Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden. Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590). |
Author | van Beek, Edwin J.R. Moss, Alastair J. Weir-McCall, Jonathan R. Newby, David E. Nicol, Edward D. Alam, Shirjel Hunter, Amanda Roditi, Giles Pawade, Tania Adamson, Philip D. Williams, Michelle C. Shah, Anoop S.V. Dweck, Marc |
AuthorAffiliation | d University of Cambridge School of Clinical Medicine, Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom c Christchurch Heart Institute, University of Otago, Christchurch, New Zealand b Edinburgh Imaging Facility QMRI, University of Edinburgh, Edinburgh, United Kingdom e Institute of Clinical Sciences, University of Glasgow, Glasgow, United Kingdom a University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom f Royal Brompton and Harefield NHS Foundation Trust Departments of Cardiology and Radiology, London, United Kingdom g National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, United Kingdom |
AuthorAffiliation_xml | – name: a University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – name: g National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, United Kingdom – name: f Royal Brompton and Harefield NHS Foundation Trust Departments of Cardiology and Radiology, London, United Kingdom – name: d University of Cambridge School of Clinical Medicine, Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom – name: c Christchurch Heart Institute, University of Otago, Christchurch, New Zealand – name: b Edinburgh Imaging Facility QMRI, University of Edinburgh, Edinburgh, United Kingdom – name: e Institute of Clinical Sciences, University of Glasgow, Glasgow, United Kingdom |
Author_xml | – sequence: 1 givenname: Michelle C. surname: Williams fullname: Williams, Michelle C. email: michelle.williams@ed.ac.uk organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 2 givenname: Alastair J. surname: Moss fullname: Moss, Alastair J. organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 3 givenname: Marc surname: Dweck fullname: Dweck, Marc organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 4 givenname: Philip D. surname: Adamson fullname: Adamson, Philip D. organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 5 givenname: Shirjel surname: Alam fullname: Alam, Shirjel organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 6 givenname: Amanda surname: Hunter fullname: Hunter, Amanda organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 7 givenname: Anoop S.V. surname: Shah fullname: Shah, Anoop S.V. organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 8 givenname: Tania surname: Pawade fullname: Pawade, Tania organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 9 givenname: Jonathan R. surname: Weir-McCall fullname: Weir-McCall, Jonathan R. organization: University of Cambridge School of Clinical Medicine, Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom – sequence: 10 givenname: Giles surname: Roditi fullname: Roditi, Giles organization: Institute of Clinical Sciences, University of Glasgow, Glasgow, United Kingdom – sequence: 11 givenname: Edwin J.R. surname: van Beek fullname: van Beek, Edwin J.R. organization: Edinburgh Imaging Facility QMRI, University of Edinburgh, Edinburgh, United Kingdom – sequence: 12 givenname: David E. surname: Newby fullname: Newby, David E. organization: University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom – sequence: 13 givenname: Edward D. surname: Nicol fullname: Nicol, Edward D. organization: Royal Brompton and Harefield NHS Foundation Trust Departments of Cardiology and Radiology, London, United Kingdom |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30678759$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUl2LEzEUDbLidlf_gA8y4IsvU_PRSTIiC0PZdYWFiq34GNPMHZs6newmmUL_jb9lf5kZuhYtuD5duDnn5J577hk66VwHCL0keEww4W_X47U2Zkwxkakxxpw_QSNSFDJnRSlO0AgLVuQEl-IUnYWwxhhzScpn6JRhLqQoyhH6NnXeddrvsspHSOVTq-96yKYr7bVJHRuiNSGrQnDG6gh19tXGVVbVW_ABslkfjdtAyGx3_zOuIJtPZ4v8-rL6vMjmsa93z9HTRrcBXjzUc_Tl6nIxvc5vZh8-Tqub3BSyjLkGUTOOtWmkwZxKzWFSaIonmDDDyZIxCkZg3HAQQjR6qRvGQEojxVLzyZKdo4u97m2_3EBtoItet-rW201yp5y26u-Xzq7Ud7dVnE2oLFkSePMg4F3aQIhqY4OBttUduD4oSkQ54SWTJEFfH0HXrvddspdQvKSUSzwIvvpzosMov5efAHQPMN6F4KE5QAhWQ8JqrYaE1ZDw0EsJJ5I8IhkbdbRucGXbx6nv91RIOWwteBWMhc5AbT2YqGpnH6dfHNFNaztrdPsDdhAOKyAqUIXVfLi-4fiIZCUleBB492-B__3-Czhj6m4 |
CitedBy_id | crossref_primary_10_1002_ccd_31307 crossref_primary_10_4070_kcj_2022_0265 crossref_primary_10_1093_eurheartj_ehz962 crossref_primary_10_3390_jcm12134550 crossref_primary_10_1038_s44161_022_00042_8 crossref_primary_10_1016_j_jacasi_2021_05_003 crossref_primary_10_1016_j_jcct_2019_07_002 crossref_primary_10_1136_heartjnl_2021_320147 crossref_primary_10_1016_j_jcct_2019_07_005 crossref_primary_10_1016_j_atherosclerosis_2022_11_008 crossref_primary_10_5551_jat_63580 crossref_primary_10_1136_heartjnl_2021_320265 crossref_primary_10_1016_j_jcct_2022_07_006 crossref_primary_10_1016_j_jcmg_2022_03_016 crossref_primary_10_1093_ehjci_jeaa051 crossref_primary_10_1093_ehjci_jeaa173 crossref_primary_10_1080_14779072_2021_1915132 crossref_primary_10_1136_openhrt_2024_002755 crossref_primary_10_2174_011573403X321064240715061250 crossref_primary_10_3390_diagnostics12071660 crossref_primary_10_1001_jamacardio_2021_3055 crossref_primary_10_1016_j_jcct_2019_07_010 crossref_primary_10_1093_eurheartj_ehac061 crossref_primary_10_1007_s10554_020_02052_8 crossref_primary_10_1016_j_hlc_2023_06_703 crossref_primary_10_1016_j_rcl_2023_05_004 crossref_primary_10_1148_ryct_240142 crossref_primary_10_1007_s10554_020_01954_x crossref_primary_10_1016_j_jcct_2021_05_004 crossref_primary_10_1016_j_crad_2019_08_023 crossref_primary_10_1016_j_jcmg_2019_11_006 crossref_primary_10_1016_j_jcmg_2023_05_011 crossref_primary_10_1093_ehjci_jeab135 crossref_primary_10_1097_MCA_0000000000001225 crossref_primary_10_1016_j_medp_2023_100001 crossref_primary_10_1093_ehjci_jeaa048 crossref_primary_10_1111_echo_70100 crossref_primary_10_1016_j_jcmg_2021_09_021 crossref_primary_10_1186_s12933_019_0878_1 crossref_primary_10_1007_s00330_024_10739_y crossref_primary_10_1016_j_jcct_2020_11_002 crossref_primary_10_1148_radiol_230524 crossref_primary_10_1016_j_jcct_2020_11_001 crossref_primary_10_1007_s00508_021_01970_4 crossref_primary_10_1016_j_jcmg_2021_02_026 crossref_primary_10_1002_clc_23686 crossref_primary_10_1016_j_jcmg_2019_03_003 crossref_primary_10_1161_CIRCULATIONAHA_123_065657 crossref_primary_10_1093_ehjci_jeac044 crossref_primary_10_1007_s10554_023_02962_3 crossref_primary_10_1016_j_clinimag_2023_06_009 crossref_primary_10_1016_j_atherosclerosis_2022_04_011 crossref_primary_10_1016_j_jacc_2020_11_005 crossref_primary_10_1016_j_atherosclerosis_2021_08_032 crossref_primary_10_1093_cvr_cvz173 crossref_primary_10_1016_j_atherosclerosis_2020_06_021 crossref_primary_10_1007_s12350_019_01832_7 crossref_primary_10_1016_j_jcct_2019_08_009 crossref_primary_10_3390_diagnostics13233574 crossref_primary_10_3389_fcvm_2021_691665 crossref_primary_10_31083_j_rcm2512442 crossref_primary_10_1007_s12410_022_09564_y crossref_primary_10_1016_j_jcct_2024_02_003 crossref_primary_10_1016_j_athplu_2021_07_021 crossref_primary_10_1016_j_atherosclerosis_2025_119105 crossref_primary_10_1186_s13073_024_01313_8 crossref_primary_10_1161_ATVBAHA_124_321504 crossref_primary_10_1016_j_jacc_2020_01_002 crossref_primary_10_1016_j_endinu_2022_03_004 crossref_primary_10_1016_j_jcct_2023_10_005 crossref_primary_10_1016_j_ejrad_2023_111282 crossref_primary_10_1016_j_jacc_2020_12_050 crossref_primary_10_1007_s00330_022_08594_w crossref_primary_10_1038_s41598_025_87118_0 crossref_primary_10_15420_usc_2021_22 crossref_primary_10_1016_j_jcmg_2019_03_033 crossref_primary_10_15420_usc_2021_30 crossref_primary_10_1007_s00395_024_01033_5 crossref_primary_10_1093_eurheartj_ehae471 crossref_primary_10_1007_s11547_020_01277_w crossref_primary_10_1016_j_jcct_2020_06_198 crossref_primary_10_1016_j_jcmg_2024_06_012 crossref_primary_10_1016_j_jacc_2024_03_386 crossref_primary_10_1093_ehjci_jeab292 crossref_primary_10_1093_ehjci_jeab293 crossref_primary_10_4250_jcvi_2021_0016 crossref_primary_10_1093_ehjci_jeaa081 crossref_primary_10_3389_fcvm_2022_997649 crossref_primary_10_1038_s41569_024_01110_1 crossref_primary_10_1007_s12471_024_01902_7 crossref_primary_10_3390_jcm9123925 crossref_primary_10_1016_j_jcct_2022_07_002 crossref_primary_10_1177_00033197231158937 crossref_primary_10_1016_j_actbio_2025_01_035 crossref_primary_10_1093_ehjci_jeae314 crossref_primary_10_1093_ehjci_jeab287 crossref_primary_10_1186_s12968_022_00858_0 crossref_primary_10_1148_radiol_222827 crossref_primary_10_36660_abc_20240608 crossref_primary_10_1016_j_rcl_2023_12_017 crossref_primary_10_3390_jcdd9100350 crossref_primary_10_1161_CIRCIMAGING_122_014611 crossref_primary_10_1093_ehjci_jeaa192 crossref_primary_10_1007_s11739_024_03672_x crossref_primary_10_3348_kjr_2022_0115 crossref_primary_10_1016_j_jcmg_2020_01_013 crossref_primary_10_2459_JCM_0000000000001235 crossref_primary_10_3390_ijms21124538 crossref_primary_10_3389_fcvm_2022_836473 crossref_primary_10_1093_eurjpc_zwab202 crossref_primary_10_1007_s12350_022_02908_7 crossref_primary_10_1177_23971983241264090 crossref_primary_10_1161_CIRCINTERVENTIONS_119_008355 crossref_primary_10_5694_mja2_52018 crossref_primary_10_1177_17539447241303399 crossref_primary_10_1016_j_amjcard_2020_11_006 crossref_primary_10_1161_CIRCIMAGING_120_011438 crossref_primary_10_1016_j_jcct_2021_07_001 crossref_primary_10_3390_diagnostics13020307 crossref_primary_10_1007_s11926_019_0875_0 crossref_primary_10_1007_s00259_019_04667_z crossref_primary_10_1016_j_jcct_2022_09_003 crossref_primary_10_1161_CIRCIMAGING_123_016152 crossref_primary_10_1016_j_tem_2019_06_001 crossref_primary_10_3390_life13020507 crossref_primary_10_1371_journal_pone_0304137 crossref_primary_10_1093_ehjci_jeaa201 crossref_primary_10_1111_eci_14188 crossref_primary_10_3390_life13030696 crossref_primary_10_3390_jcdd11080245 crossref_primary_10_2337_dc21_1663 crossref_primary_10_1016_j_jcct_2019_06_017 crossref_primary_10_1093_ehjci_jeaa208 crossref_primary_10_3389_fcvm_2023_1143119 crossref_primary_10_17816_DD71633 crossref_primary_10_1148_radiol_2021204704 crossref_primary_10_1016_j_jcct_2024_05_232 crossref_primary_10_1148_ryct_220183 crossref_primary_10_1007_s11886_022_01825_y crossref_primary_10_1016_j_jcct_2019_10_006 crossref_primary_10_4244_EIJ_E_24_00004 crossref_primary_10_1016_j_jcmg_2021_10_009 crossref_primary_10_1148_ryct_230090 crossref_primary_10_1259_bjr_20190921 crossref_primary_10_1016_j_jacc_2020_06_076 crossref_primary_10_1148_ryct_210260 crossref_primary_10_1016_j_jacasi_2024_04_001 crossref_primary_10_1016_j_jacc_2021_06_019 crossref_primary_10_1093_eurheartj_suab072 crossref_primary_10_1016_j_endien_2022_11_009 crossref_primary_10_1161_CIRCIMAGING_123_016057 crossref_primary_10_1007_s00330_025_11353_2 crossref_primary_10_1016_j_jjcc_2021_12_006 crossref_primary_10_2459_JCM_0000000000001433 crossref_primary_10_1161_CIRCULATIONAHA_119_044720 crossref_primary_10_1093_ehjci_jeaa022 crossref_primary_10_1007_s00330_021_08429_0 crossref_primary_10_3390_jcm10030521 crossref_primary_10_31083_j_rcm2501027 crossref_primary_10_1016_j_jcmg_2022_04_024 crossref_primary_10_1038_s41598_022_08425_4 crossref_primary_10_1001_jamacardio_2021_5705 crossref_primary_10_1016_j_jcct_2024_12_083 crossref_primary_10_1093_ehjci_jeaa130 crossref_primary_10_7326_M22_3027 crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106719 crossref_primary_10_1007_s11883_022_01029_3 crossref_primary_10_1016_j_acvd_2022_07_001 crossref_primary_10_1016_j_ejrad_2022_110601 crossref_primary_10_1148_ryct_220188 crossref_primary_10_1093_ehjcr_ytab095 crossref_primary_10_3892_etm_2019_8371 crossref_primary_10_7326_L23_0262 crossref_primary_10_3389_fcvm_2021_716832 crossref_primary_10_1080_21548331_2022_2030630 crossref_primary_10_1111_1754_9485_13817 crossref_primary_10_1007_s12350_019_01901_x crossref_primary_10_1177_17539447241249650 crossref_primary_10_1016_j_jcmg_2021_03_004 crossref_primary_10_1016_j_jcct_2024_10_011 crossref_primary_10_1177_00033197241233634 crossref_primary_10_1016_j_jcct_2024_10_013 crossref_primary_10_1016_j_jcmg_2022_05_014 crossref_primary_10_1148_ryct_210171 crossref_primary_10_4244_EIJ_E_22_00051 crossref_primary_10_1007_s00059_023_05207_0 crossref_primary_10_1016_j_pcad_2022_10_013 crossref_primary_10_3390_jcm13061556 crossref_primary_10_4070_kcj_2019_0315 crossref_primary_10_1016_j_jcct_2019_05_010 crossref_primary_10_1007_s10554_023_02918_7 crossref_primary_10_1016_j_jacc_2020_05_078 crossref_primary_10_1097_MD_0000000000028801 crossref_primary_10_1148_radiol_213271 crossref_primary_10_1186_s12933_022_01615_4 crossref_primary_10_1093_eurheartj_ehz592 crossref_primary_10_1161_CIRCIMAGING_123_016143 crossref_primary_10_31083_j_rcm2408245 crossref_primary_10_3390_jpm15030100 crossref_primary_10_1055_a_2499_3122 crossref_primary_10_1007_s10554_021_02429_3 crossref_primary_10_1016_j_ejrad_2021_109551 crossref_primary_10_1016_j_jid_2022_05_1085 crossref_primary_10_1093_eurheartj_ehae177 crossref_primary_10_1148_radiol_240876 crossref_primary_10_36660_abc_20240608i crossref_primary_10_1016_j_jcct_2024_04_009 crossref_primary_10_1161_CIRCULATIONAHA_122_060308 crossref_primary_10_1007_s12350_020_02086_4 crossref_primary_10_1016_j_ancard_2022_10_002 crossref_primary_10_54912_jci_2022_0025 crossref_primary_10_1016_j_jcmg_2019_09_011 crossref_primary_10_1016_j_jcmg_2019_09_012 crossref_primary_10_1016_j_jcmg_2023_08_006 crossref_primary_10_17816_mechnikov629024 crossref_primary_10_3390_app13010241 crossref_primary_10_1016_j_jcmg_2023_08_005 crossref_primary_10_1186_s12968_021_00758_9 crossref_primary_10_1016_j_jcmg_2023_08_002 crossref_primary_10_1161_CIRCIMAGING_121_012514 crossref_primary_10_1016_j_atherosclerosis_2020_03_008 crossref_primary_10_1259_bjr_20190880 crossref_primary_10_1161_CIRCIMAGING_123_015236 crossref_primary_10_1016_j_atherosclerosis_2020_03_001 crossref_primary_10_3390_diagnostics13122074 crossref_primary_10_1016_j_ejrad_2022_110269 crossref_primary_10_1007_s10554_020_01926_1 crossref_primary_10_3390_jcm12030903 crossref_primary_10_1007_s10554_022_02785_8 crossref_primary_10_1002_lt_25869 crossref_primary_10_1016_j_jcmg_2023_08_018 crossref_primary_10_1038_s41598_023_38675_9 crossref_primary_10_1093_eurheartj_ehab405 crossref_primary_10_1007_s11886_023_01982_8 crossref_primary_10_3389_fcvm_2023_1235144 crossref_primary_10_1136_heartjnl_2019_315607 crossref_primary_10_1259_bjr_20190740 crossref_primary_10_1007_s00259_024_07055_4 crossref_primary_10_1007_s00330_021_07726_y crossref_primary_10_1016_j_atherosclerosis_2020_03_019 crossref_primary_10_1007_s00330_022_08894_1 crossref_primary_10_1016_j_ajpc_2021_100294 crossref_primary_10_1016_j_jcmg_2020_11_007 crossref_primary_10_1016_j_jcmg_2022_06_001 crossref_primary_10_1007_s10140_021_01973_8 crossref_primary_10_3390_jcm11030477 crossref_primary_10_1016_j_clinthera_2023_09_019 crossref_primary_10_1038_s41467_021_26146_6 crossref_primary_10_1007_s11886_022_01831_0 crossref_primary_10_1016_j_jcmg_2023_08_021 crossref_primary_10_1016_j_pcad_2023_09_001 crossref_primary_10_1007_s11883_020_00879_z crossref_primary_10_1016_j_jacadv_2022_100078 crossref_primary_10_1016_j_jacc_2022_03_381 crossref_primary_10_3390_jcm10040625 crossref_primary_10_1097_RTI_0000000000000711 crossref_primary_10_1186_s12880_024_01325_1 crossref_primary_10_1259_bjr_20220346 crossref_primary_10_1259_bjr_20190763 crossref_primary_10_1007_s00330_023_09888_3 crossref_primary_10_1016_j_jcct_2021_02_002 crossref_primary_10_1001_jamacardio_2023_4390 crossref_primary_10_2478_jim_2021_0007 crossref_primary_10_2478_jim_2021_0006 crossref_primary_10_2478_jim_2021_0005 crossref_primary_10_2478_jim_2021_0008 crossref_primary_10_1055_a_2307_5162 crossref_primary_10_1016_j_jcmg_2024_02_001 crossref_primary_10_1093_ehjci_jez031 crossref_primary_10_3390_life13051086 crossref_primary_10_1016_j_metabol_2022_155370 crossref_primary_10_1016_j_jphs_2019_12_005 crossref_primary_10_1016_j_jacc_2021_10_044 crossref_primary_10_1007_s11604_024_01543_1 crossref_primary_10_3389_fcvm_2021_775115 crossref_primary_10_1136_heartjnl_2020_318269 crossref_primary_10_1148_radiol_223342 crossref_primary_10_7759_cureus_78365 crossref_primary_10_1016_j_jcct_2024_06_009 crossref_primary_10_1038_s41569_023_00900_3 crossref_primary_10_1016_j_atherosclerosis_2023_02_005 crossref_primary_10_1016_j_jcmg_2020_04_027 crossref_primary_10_1161_JAHA_121_022697 crossref_primary_10_36660_abc_20230105 crossref_primary_10_1161_CIRCIMAGING_120_011199 crossref_primary_10_1016_j_jacc_2019_03_465 crossref_primary_10_1007_s00330_023_10439_z crossref_primary_10_1016_j_jcct_2020_08_007 crossref_primary_10_1148_ryct_2021200563 crossref_primary_10_1097_HCO_0000000000001077 crossref_primary_10_1016_j_amjmed_2021_03_014 crossref_primary_10_1161_JAHA_123_033639 crossref_primary_10_1016_j_jcct_2022_02_005 crossref_primary_10_1016_j_jcmg_2021_12_015 crossref_primary_10_1007_s11936_020_00818_w crossref_primary_10_1016_j_jcct_2022_02_002 crossref_primary_10_1016_j_hlc_2022_12_003 crossref_primary_10_1016_j_jcmg_2022_07_002 crossref_primary_10_1093_ehjci_jez253 crossref_primary_10_1016_j_atherosclerosis_2022_01_020 crossref_primary_10_3390_jcm12247615 crossref_primary_10_1016_j_jcmg_2020_03_002 crossref_primary_10_1097_MCA_0000000000000851 crossref_primary_10_1016_j_jcmg_2023_10_002 crossref_primary_10_4274_dir_2023_232196 crossref_primary_10_1016_j_atherosclerosis_2024_117579 crossref_primary_10_1016_j_jcmg_2019_07_011 crossref_primary_10_3390_diagnostics13010125 crossref_primary_10_1016_j_jcct_2019_03_007 crossref_primary_10_15836_ccar2020_193 crossref_primary_10_1016_j_jcin_2023_03_041 crossref_primary_10_1016_j_jjcc_2024_05_009 crossref_primary_10_1155_2021_5597467 crossref_primary_10_1093_ehjqcco_qcaa006 crossref_primary_10_1016_j_clinimag_2022_08_005 crossref_primary_10_1016_j_jcmg_2021_11_007 crossref_primary_10_1007_s00330_020_07037_8 crossref_primary_10_1016_j_atherosclerosis_2024_117449 crossref_primary_10_1148_radiol_2020200605 crossref_primary_10_1007_s00117_024_01287_z crossref_primary_10_1007_s11883_024_01205_7 crossref_primary_10_1093_ehjci_jeae029 crossref_primary_10_1186_s12933_024_02527_1 crossref_primary_10_1186_s41747_023_00410_4 crossref_primary_10_1007_s10554_020_01802_y crossref_primary_10_1007_s11883_023_01178_z crossref_primary_10_2478_jce_2023_0015 crossref_primary_10_1161_ATVBAHA_119_312899 crossref_primary_10_3390_diagnostics14151671 crossref_primary_10_1259_bjr_20180309 crossref_primary_10_3390_diagnostics12061446 crossref_primary_10_1007_s10554_024_03149_0 crossref_primary_10_1038_s44161_024_00420_4 crossref_primary_10_1097_MCA_0000000000001292 crossref_primary_10_1016_j_jcmg_2020_05_040 crossref_primary_10_3390_tomography9050140 crossref_primary_10_1016_j_jcmg_2019_05_009 crossref_primary_10_1259_bjr_20220885 crossref_primary_10_1007_s00330_023_10223_z crossref_primary_10_33590_emjradiol_10308328 crossref_primary_10_1111_echo_70032 crossref_primary_10_1016_j_atherosclerosis_2024_117580 crossref_primary_10_1136_heartjnl_2022_321360 crossref_primary_10_1136_bcr_2019_232104 crossref_primary_10_4274_jmsr_galenos_2023_2023_9_1 crossref_primary_10_1016_j_jcct_2021_03_010 crossref_primary_10_1016_j_jcct_2019_09_009 crossref_primary_10_3390_jcdd9100329 crossref_primary_10_3389_fcvm_2021_743538 crossref_primary_10_1148_radiol_221784 crossref_primary_10_1038_s41598_022_19546_1 crossref_primary_10_3389_fcvm_2025_1543816 crossref_primary_10_1097_MCA_0000000000001190 crossref_primary_10_1002_jcu_23680 crossref_primary_10_1016_j_jacc_2023_09_817 crossref_primary_10_1016_j_jacasi_2024_09_009 crossref_primary_10_1016_j_jcct_2024_01_012 crossref_primary_10_1016_j_jcmg_2018_11_037 crossref_primary_10_1001_jamacardio_2020_1567 crossref_primary_10_1093_bjr_tqae216 crossref_primary_10_1016_j_jcmg_2021_06_001 crossref_primary_10_1093_eurheartj_ehac597 crossref_primary_10_23736_S0026_4806_20_06759_2 crossref_primary_10_1007_s12350_019_02004_3 crossref_primary_10_1136_bmjopen_2021_058304 crossref_primary_10_1136_heartjnl_2024_324858 crossref_primary_10_3348_jksr_2021_0170 crossref_primary_10_1111_bph_14868 crossref_primary_10_1148_radiol_230124 crossref_primary_10_1161_JAHA_123_029950 crossref_primary_10_1016_j_tcm_2021_08_014 crossref_primary_10_1016_j_jcmg_2020_06_034 crossref_primary_10_1111_bph_14896 crossref_primary_10_1148_ryct_230313 crossref_primary_10_3390_healthcare12050520 crossref_primary_10_1093_ehjci_jez089 crossref_primary_10_1016_j_atherosclerosis_2024_118593 crossref_primary_10_1016_j_atherosclerosis_2019_06_914 crossref_primary_10_1093_eurheartj_ehz930 crossref_primary_10_1161_CIRCULATIONAHA_121_057789 crossref_primary_10_1016_j_tcm_2021_08_009 crossref_primary_10_1556_1647_2021_00033 crossref_primary_10_1148_radiol_2020192791 crossref_primary_10_1016_j_ajpc_2022_100432 crossref_primary_10_1007_s00398_024_00663_0 crossref_primary_10_1016_j_acra_2022_09_004 crossref_primary_10_1016_j_jacadv_2024_100861 crossref_primary_10_1097_CD9_0000000000000126 crossref_primary_10_1016_j_crad_2019_06_034 crossref_primary_10_1002_clc_23989 crossref_primary_10_3390_jcm11195663 crossref_primary_10_1007_s00330_023_09721_x crossref_primary_10_1161_CIRCIMAGING_124_017066 crossref_primary_10_1097_MOL_0000000000000645 crossref_primary_10_1007_s11845_024_03745_y crossref_primary_10_1097_MD_0000000000039595 crossref_primary_10_1371_journal_pone_0240539 crossref_primary_10_1016_j_jcct_2021_10_010 crossref_primary_10_1186_s12883_024_03788_9 crossref_primary_10_1097_LVT_0000000000000215 crossref_primary_10_1093_bjr_tqae246 crossref_primary_10_1093_ehjci_jead072 crossref_primary_10_1161_CIRCULATIONAHA_120_049840 crossref_primary_10_1016_j_jacr_2022_09_012 crossref_primary_10_1148_ryct_2019190069 crossref_primary_10_1148_radiol_221693 crossref_primary_10_1161_ATVBAHA_123_320065 crossref_primary_10_1016_j_jcct_2025_01_007 crossref_primary_10_4244_EIJ_D_23_00487 crossref_primary_10_1016_j_jacc_2018_11_017 crossref_primary_10_1148_ryct_240242 crossref_primary_10_1055_a_1395_7905 |
Cites_doi | 10.1136/hrt.2006.108167 10.1016/j.jcct.2017.11.014 10.1097/RLI.0b013e31828fdf9f 10.1161/CIRCIMAGING.116.004896 10.1136/heart.83.3.361 10.1001/jamainternmed.2016.7585 10.1016/j.jcct.2017.09.001 10.1016/j.jacc.2018.02.079 10.1136/hrt.82.3.265 10.1016/0735-1097(90)90282-T 10.1016/0735-1097(93)90050-B 10.1034/j.1600-0854.2003.8042.x 10.1093/ehjci/jev325 10.1161/CIRCULATIONAHA.116.024360 10.1016/j.jacc.2015.05.069 10.1016/S0140-6736(15)60291-4 10.1016/j.jacc.2016.02.026 10.1186/1745-6215-13-184 10.1136/openhrt-2014-000234 10.1056/NEJMoa1805971 10.1161/01.CIR.51.4.5 10.1016/j.jacc.2007.03.044 10.1016/j.jacc.2009.02.068 10.1016/j.jacc.2012.10.054 10.1016/j.jcmg.2012.03.019 10.1161/CIRCULATIONAHA.117.030578 10.1016/0735-1097(90)90298-4 10.1007/s12350-014-9865-9 10.1001/jama.2014.14681 10.1161/CIRCULATIONAHA.117.031178 10.1001/jamacardio.2017.4973 10.1161/CIRCULATIONAHA.105.580696 10.1016/j.jcmg.2018.04.015 10.1253/circj.71.363 |
ContentType | Journal Article |
Copyright | 2019 The Authors The Authors Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. Copyright Elsevier Limited Jan 29, 2019 2019 The Authors 2019 |
Copyright_xml | – notice: 2019 The Authors – notice: The Authors – notice: Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Jan 29, 2019 – notice: 2019 The Authors 2019 |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TK H94 K9. NAPCQ 7X8 5PM |
DOI | 10.1016/j.jacc.2018.10.066 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-3597 |
EndPage | 301 |
ExternalDocumentID | PMC6342893 30678759 10_1016_j_jacc_2018_10_066 S0735109718392106 1_s2_0_S0735109718392106 |
Genre | Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: British Heart Foundation grantid: FS/14/78/31020 – fundername: Chief Scientist Office grantid: CZH/4/588 – fundername: Chief Scientist Office grantid: PCL/17/04 – fundername: British Heart Foundation grantid: RE/13/3/30183 – fundername: British Heart Foundation grantid: FS/11/014 – fundername: British Heart Foundation grantid: FS/16/19/31982 – fundername: British Heart Foundation grantid: CH/09/002 – fundername: Medical Research Council grantid: G0701127 – fundername: Wellcome Trust grantid: WT103782AIA |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 18M 1B1 1P~ 1~. 1~5 2WC 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ AABNK AABVL AAEDT AAEDW AAIKJ AALRI AAOAW AAQFI AAQQT AAXUO ABBQC ABFNM ABFRF ABLJU ABMAC ABMZM ABOCM ACGFO ACGFS ACIUM ACJTP ACPRK ACVFH ADBBV ADCNI ADEZE ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFPUW AFRAH AFRHN AFTJW AGCQF AGYEJ AHMBA AIGII AITUG AJRQY AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BLXMC CS3 DIK DU5 E3Z EBS EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FNPLU G-Q GBLVA GX1 HVGLF IHE IXB J1W K-O KQ8 L7B MO0 N9A O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ Q38 ROL RPZ SCC SDF SDG SDP SES SSZ TR2 UNMZH UV1 W8F WH7 WOQ WOW YYM YZZ Z5R .55 .GJ 0SF 1CY 29L 3O- 3V. 6I. 7RV AACTN AAFTH AAKUH AAQXK AAYOK ABVKL ABWVN ABXDB ACRPL ADMUD ADNMO AFCTW AFETI AFFNX AGHFR AJOXV AMFUW ASPBG AVWKF AZFZN BENPR BPHCQ FGOYB H13 HX~ HZ~ J5H N4W NCXOZ PROAC QTD R2- RIG SEW T5K X7M XPP YYP ZGI ZXP AAIAV ABJNI EFLBG LCYCR NAHTW ZA5 AAYWO AAYXX AGQPQ CITATION CGR CUY CVF ECM EIF NPM 7T5 7TK H94 K9. NAPCQ 7X8 5PM |
ID | FETCH-LOGICAL-c589t-ae7d360acf8c0628a6e45a204013c61b332ec700f6e777fabaf33e88c87ba64b3 |
IEDL.DBID | IXB |
ISSN | 0735-1097 1558-3597 |
IngestDate | Thu Aug 21 13:44:34 EDT 2025 Fri Jul 11 00:14:50 EDT 2025 Fri Jul 25 09:25:11 EDT 2025 Mon Jul 21 05:36:05 EDT 2025 Tue Jul 01 04:22:36 EDT 2025 Thu Apr 24 23:05:29 EDT 2025 Fri Feb 23 02:45:22 EST 2024 Sun Feb 23 10:18:58 EST 2025 Tue Aug 26 19:31:39 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | computed tomography coronary artery disease CT CTA AU CI HR IQR atherosclerotic plaque coronary angiography computed tomography angiography interquartile range Agatston units hazard ratio confidence interval |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c589t-ae7d360acf8c0628a6e45a204013c61b332ec700f6e777fabaf33e88c87ba64b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0735109718392106 |
PMID | 30678759 |
PQID | 2169226803 |
PQPubID | 2031078 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6342893 proquest_miscellaneous_2179469381 proquest_journals_2169226803 pubmed_primary_30678759 crossref_primary_10_1016_j_jacc_2018_10_066 crossref_citationtrail_10_1016_j_jacc_2018_10_066 elsevier_sciencedirect_doi_10_1016_j_jacc_2018_10_066 elsevier_clinicalkeyesjournals_1_s2_0_S0735109718392106 elsevier_clinicalkey_doi_10_1016_j_jacc_2018_10_066 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-01-29 |
PublicationDateYYYYMMDD | 2019-01-29 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-29 day: 29 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | Journal of the American College of Cardiology |
PublicationTitleAlternate | J Am Coll Cardiol |
PublicationYear | 2019 |
Publisher | Elsevier Inc Elsevier Limited Elsevier Biomedical |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited – name: Elsevier Biomedical |
References | Narula, Nakano, Virmani (bib19) 2013; 61 Naoum, Berman, Ahmadi (bib34) 2017; 10 Van Lierde, De Geest, Verstraete, Van de Werf (bib24) 1990; 16 Motoyama, Sarai, Harigaya (bib3) 2009; 54 Lee, Chang, Sung (bib32) 2018; 11 Agatston, Janowitz, Hildner, Zusmer, Viamonte, Detrano (bib11) 1990; 15 Schlett, Maurovich-Horvat, Ferencik (bib18) 2013; 48 Chang, Lin, Lee (bib25) 2018; 71 Davies (bib22) 2000; 83 Joseph, Ackerman, Talley, Johnstone, Kupersmith (bib33) 1993; 22 Ferencik, Mayrhofer, Bittner (bib21) 2018; 3 Newby (bib30) 2017; 136 Conte, Annoni, Pontone (bib5) 2017; 18 Austen, Edwards, Frye (bib12) 1975; 51 Mann, Davies (bib26) 1999; 82 Hoffmann, Ferencik, Udelson (bib36) 2017; 135 Maddox, Stanislawski, Grunwald (bib23) 2014; 312 Motoyama, Ito, Sarai (bib2) 2015; 66 Takamura, Fujimoto, Kondo (bib29) 2017 Motoyama, Kondo, Sarai (bib17) 2007; 50 Obaid, Calvert, Brown (bib20) 2017; 11 (bib6) 2018; 379 (bib7) 2015; 385 Maroules, Hamilton-Craig, Branch (bib16) 2018; 12 Thomsen, Abdulla (bib4) 2016; 17 Motoyama, Kondo, Anno (bib14) 2007; 71 Virmani, Burke, Kolodgie, Farb (bib1) 2003; 16 Shah, Bellam, Leipsic (bib27) 2014; 21 Williams, Hunter, Shah (bib8) 2016; 67 Redberg, Katz (bib35) 2017; 177 Newby, Williams, Flapan (bib9) 2012; 13 Budoff, Mayrhofer, Ferencik (bib31) 2017; 136 Williams, Golay, Hunter (bib13) 2015; 2 McClelland, Chung, Detrano, Post, Kronmal (bib28) 2006; 113 Maurovich-Horvat, Schlett, Alkadhi (bib15) 2012; 5 Woodward, Brindle, Tunstall-Pedoe (bib10) 2007; 93 Motoyama (10.1016/j.jacc.2018.10.066_bib3) 2009; 54 Maddox (10.1016/j.jacc.2018.10.066_bib23) 2014; 312 Motoyama (10.1016/j.jacc.2018.10.066_bib17) 2007; 50 Hoffmann (10.1016/j.jacc.2018.10.066_bib36) 2017; 135 Conte (10.1016/j.jacc.2018.10.066_bib5) 2017; 18 Agatston (10.1016/j.jacc.2018.10.066_bib11) 1990; 15 Austen (10.1016/j.jacc.2018.10.066_bib12) 1975; 51 Woodward (10.1016/j.jacc.2018.10.066_bib10) 2007; 93 Schlett (10.1016/j.jacc.2018.10.066_bib18) 2013; 48 McClelland (10.1016/j.jacc.2018.10.066_bib28) 2006; 113 Virmani (10.1016/j.jacc.2018.10.066_bib1) 2003; 16 Thomsen (10.1016/j.jacc.2018.10.066_bib4) 2016; 17 Williams (10.1016/j.jacc.2018.10.066_bib8) 2016; 67 Motoyama (10.1016/j.jacc.2018.10.066_bib2) 2015; 66 Joseph (10.1016/j.jacc.2018.10.066_bib33) 1993; 22 Chang (10.1016/j.jacc.2018.10.066_bib25) 2018; 71 Obaid (10.1016/j.jacc.2018.10.066_bib20) 2017; 11 Ferencik (10.1016/j.jacc.2018.10.066_bib21) 2018; 3 Maurovich-Horvat (10.1016/j.jacc.2018.10.066_bib15) 2012; 5 Williams (10.1016/j.jacc.2018.10.066_bib13) 2015; 2 Shah (10.1016/j.jacc.2018.10.066_bib27) 2014; 21 Takamura (10.1016/j.jacc.2018.10.066_bib29) 2017 Budoff (10.1016/j.jacc.2018.10.066_bib31) 2017; 136 Redberg (10.1016/j.jacc.2018.10.066_bib35) 2017; 177 Motoyama (10.1016/j.jacc.2018.10.066_bib14) 2007; 71 (10.1016/j.jacc.2018.10.066_bib7) 2015; 385 Narula (10.1016/j.jacc.2018.10.066_bib19) 2013; 61 Davies (10.1016/j.jacc.2018.10.066_bib22) 2000; 83 Mann (10.1016/j.jacc.2018.10.066_bib26) 1999; 82 Naoum (10.1016/j.jacc.2018.10.066_bib34) 2017; 10 (10.1016/j.jacc.2018.10.066_bib6) 2018; 379 Van Lierde (10.1016/j.jacc.2018.10.066_bib24) 1990; 16 Lee (10.1016/j.jacc.2018.10.066_bib32) 2018; 11 Newby (10.1016/j.jacc.2018.10.066_bib9) 2012; 13 Maroules (10.1016/j.jacc.2018.10.066_bib16) 2018; 12 Newby (10.1016/j.jacc.2018.10.066_bib30) 2017; 136 30678760 - J Am Coll Cardiol. 2019 Jan 29;73(3):302-304. doi: 10.1016/j.jacc.2018.11.017. |
References_xml | – volume: 82 start-page: 265 year: 1999 end-page: 268 ident: bib26 article-title: Mechanisms of progression in native coronary artery disease: role of healed plaque disruption publication-title: Heart – volume: 11 start-page: 1475 year: 2018 end-page: 1484 ident: bib32 article-title: Effects of statins on coronary atherosclerotic plaques: The PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) Study publication-title: J Am Coll Cardiol Img – volume: 15 start-page: 827 year: 1990 end-page: 832 ident: bib11 article-title: Quantification of coronary artery calcium using ultrafast computed tomography publication-title: J Am Coll Cardiol – volume: 67 start-page: 1759 year: 2016 end-page: 1768 ident: bib8 article-title: Use of coronary computed tomographic angiography to guide management of patients with coronary disease publication-title: J Am Coll Cardiol – volume: 66 start-page: 337 year: 2015 end-page: 346 ident: bib2 article-title: Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up publication-title: J Am Coll Cardiol – volume: 18 start-page: 1170 year: 2017 end-page: 1178 ident: bib5 article-title: Evaluation of coronary plaque characteristics with coronary computed tomography angiography in patients with non-obstructive coronary artery disease: a long-term follow-up study publication-title: Eur Heart J Cardiovasc Imaging – start-page: 39115 year: 2017 ident: bib29 article-title: Incremental prognostic value of coronary computed tomography angiography: high-risk plaque characteristics in asymptomatic patients publication-title: J Atheroscler Thromb – volume: 312 start-page: 1754 year: 2014 end-page: 1763 ident: bib23 article-title: Nonobstructive coronary artery disease and risk of myocardial infarction publication-title: JAMA – volume: 135 start-page: 2320 year: 2017 end-page: 2332 ident: bib36 article-title: Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) publication-title: Circulation – volume: 22 start-page: 459 year: 1993 end-page: 467 ident: bib33 article-title: Manifestations of coronary atherosclerosis in young trauma victims—an autopsy study publication-title: J Am Coll Cardiol – volume: 50 start-page: 319 year: 2007 end-page: 326 ident: bib17 article-title: Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes publication-title: J Am Coll Cardiol – volume: 177 start-page: 21 year: 2017 end-page: 23 ident: bib35 article-title: Statins for primary prevention: the debate is intense, but the data are weak publication-title: JAMA Intern Med – volume: 93 start-page: 172 year: 2007 end-page: 176 ident: bib10 article-title: Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) publication-title: Heart – volume: 10 start-page: e004896 year: 2017 ident: bib34 article-title: Predictive value of age- and sex-specific nomograms of global plaque burden on coronary computed tomography angiography for major cardiac events publication-title: Circ Cardiovasc Imaging – volume: 2 start-page: e000234 year: 2015 ident: bib13 article-title: Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial publication-title: Open Heart – volume: 51 start-page: 5 year: 1975 end-page: 40 ident: bib12 article-title: A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association publication-title: Circulation – volume: 3 start-page: 144 year: 2018 end-page: 152 ident: bib21 article-title: Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial publication-title: JAMA Cardiol – volume: 48 start-page: 646 year: 2013 end-page: 653 ident: bib18 article-title: Histogram analysis of lipid-core plaques in coronary computed tomographic angiography: ex vivo validation against histology publication-title: Invest Radiol – volume: 21 start-page: 453 year: 2014 end-page: 466 ident: bib27 article-title: Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease publication-title: J Nucl Cardiol – volume: 83 start-page: 361 year: 2000 end-page: 366 ident: bib22 article-title: The pathophysiology of acute coronary syndromes publication-title: Heart – volume: 113 start-page: 30 year: 2006 end-page: 37 ident: bib28 article-title: Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA) publication-title: Circulation – volume: 61 start-page: 1041 year: 2013 end-page: 1051 ident: bib19 article-title: Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques publication-title: J Am Coll Cardiol – volume: 71 start-page: 363 year: 2007 end-page: 366 ident: bib14 article-title: Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging publication-title: Circ J – volume: 379 start-page: 924 year: 2018 end-page: 933 ident: bib6 article-title: CT coronary angiography and 5 year risk of myocardial infarction publication-title: N Engl J Med – volume: 11 start-page: 455 year: 2017 end-page: 461 ident: bib20 article-title: Coronary CT angiography features of ruptured and high-risk atherosclerotic plaques: correlation with intra-vascular ultrasound publication-title: J Cardiovasc Comput Tomogr – volume: 16 start-page: 267 year: 2003 end-page: 272 ident: bib1 article-title: Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque publication-title: J Interven Cardiol – volume: 136 start-page: 1993 year: 2017 end-page: 2005 ident: bib31 article-title: Prognostic value of coronary artery calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) publication-title: Circulation – volume: 5 start-page: 1243 year: 2012 end-page: 1252 ident: bib15 article-title: The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography publication-title: J Am Coll Cardiol Img – volume: 17 start-page: 120 year: 2016 end-page: 129 ident: bib4 article-title: Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis publication-title: Eur Heart J Cardiovasc Imaging – volume: 16 start-page: 1545 year: 1990 end-page: 1549 ident: bib24 article-title: Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis publication-title: J Am Coll Cardiol – volume: 13 start-page: 184 year: 2012 ident: bib9 article-title: Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial publication-title: Trials – volume: 385 start-page: 2383 year: 2015 end-page: 2391 ident: bib7 article-title: CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial publication-title: Lancet – volume: 71 start-page: 2511 year: 2018 end-page: 2522 ident: bib25 article-title: Coronary atherosclerotic precursors of acute coronary syndromes publication-title: J Am Coll Cardiol – volume: 12 start-page: 125 year: 2018 end-page: 130 ident: bib16 article-title: Coronary artery disease reporting and data system (CAD-RADSTM): Inter-observer agreement for assessment categories and modifiers publication-title: J Cardiovasc Comput Tomogr – volume: 54 start-page: 49 year: 2009 end-page: 57 ident: bib3 article-title: Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome publication-title: J Am Coll Cardiol – volume: 136 start-page: 2006 year: 2017 end-page: 2008 ident: bib30 article-title: Computed tomography or functional stress testing for the prediction of risk: can i have my cake and eat it? publication-title: Circulation – volume: 93 start-page: 172 year: 2007 ident: 10.1016/j.jacc.2018.10.066_bib10 article-title: Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) publication-title: Heart doi: 10.1136/hrt.2006.108167 – volume: 12 start-page: 125 year: 2018 ident: 10.1016/j.jacc.2018.10.066_bib16 article-title: Coronary artery disease reporting and data system (CAD-RADSTM): Inter-observer agreement for assessment categories and modifiers publication-title: J Cardiovasc Comput Tomogr doi: 10.1016/j.jcct.2017.11.014 – volume: 48 start-page: 646 year: 2013 ident: 10.1016/j.jacc.2018.10.066_bib18 article-title: Histogram analysis of lipid-core plaques in coronary computed tomographic angiography: ex vivo validation against histology publication-title: Invest Radiol doi: 10.1097/RLI.0b013e31828fdf9f – volume: 10 start-page: e004896 year: 2017 ident: 10.1016/j.jacc.2018.10.066_bib34 article-title: Predictive value of age- and sex-specific nomograms of global plaque burden on coronary computed tomography angiography for major cardiac events publication-title: Circ Cardiovasc Imaging doi: 10.1161/CIRCIMAGING.116.004896 – volume: 83 start-page: 361 year: 2000 ident: 10.1016/j.jacc.2018.10.066_bib22 article-title: The pathophysiology of acute coronary syndromes publication-title: Heart doi: 10.1136/heart.83.3.361 – volume: 177 start-page: 21 year: 2017 ident: 10.1016/j.jacc.2018.10.066_bib35 article-title: Statins for primary prevention: the debate is intense, but the data are weak publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2016.7585 – volume: 11 start-page: 455 year: 2017 ident: 10.1016/j.jacc.2018.10.066_bib20 article-title: Coronary CT angiography features of ruptured and high-risk atherosclerotic plaques: correlation with intra-vascular ultrasound publication-title: J Cardiovasc Comput Tomogr doi: 10.1016/j.jcct.2017.09.001 – volume: 71 start-page: 2511 year: 2018 ident: 10.1016/j.jacc.2018.10.066_bib25 article-title: Coronary atherosclerotic precursors of acute coronary syndromes publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.02.079 – volume: 82 start-page: 265 year: 1999 ident: 10.1016/j.jacc.2018.10.066_bib26 article-title: Mechanisms of progression in native coronary artery disease: role of healed plaque disruption publication-title: Heart doi: 10.1136/hrt.82.3.265 – volume: 15 start-page: 827 year: 1990 ident: 10.1016/j.jacc.2018.10.066_bib11 article-title: Quantification of coronary artery calcium using ultrafast computed tomography publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(90)90282-T – volume: 22 start-page: 459 year: 1993 ident: 10.1016/j.jacc.2018.10.066_bib33 article-title: Manifestations of coronary atherosclerosis in young trauma victims—an autopsy study publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(93)90050-B – volume: 16 start-page: 267 year: 2003 ident: 10.1016/j.jacc.2018.10.066_bib1 article-title: Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque publication-title: J Interven Cardiol doi: 10.1034/j.1600-0854.2003.8042.x – volume: 17 start-page: 120 year: 2016 ident: 10.1016/j.jacc.2018.10.066_bib4 article-title: Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis publication-title: Eur Heart J Cardiovasc Imaging doi: 10.1093/ehjci/jev325 – volume: 135 start-page: 2320 year: 2017 ident: 10.1016/j.jacc.2018.10.066_bib36 article-title: Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.024360 – volume: 66 start-page: 337 year: 2015 ident: 10.1016/j.jacc.2018.10.066_bib2 article-title: Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.05.069 – volume: 385 start-page: 2383 year: 2015 ident: 10.1016/j.jacc.2018.10.066_bib7 article-title: CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial publication-title: Lancet doi: 10.1016/S0140-6736(15)60291-4 – volume: 67 start-page: 1759 year: 2016 ident: 10.1016/j.jacc.2018.10.066_bib8 article-title: Use of coronary computed tomographic angiography to guide management of patients with coronary disease publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.02.026 – volume: 13 start-page: 184 year: 2012 ident: 10.1016/j.jacc.2018.10.066_bib9 article-title: Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial publication-title: Trials doi: 10.1186/1745-6215-13-184 – volume: 2 start-page: e000234 year: 2015 ident: 10.1016/j.jacc.2018.10.066_bib13 article-title: Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial publication-title: Open Heart doi: 10.1136/openhrt-2014-000234 – volume: 379 start-page: 924 year: 2018 ident: 10.1016/j.jacc.2018.10.066_bib6 article-title: CT coronary angiography and 5 year risk of myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa1805971 – volume: 51 start-page: 5 year: 1975 ident: 10.1016/j.jacc.2018.10.066_bib12 article-title: A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association publication-title: Circulation doi: 10.1161/01.CIR.51.4.5 – volume: 50 start-page: 319 year: 2007 ident: 10.1016/j.jacc.2018.10.066_bib17 article-title: Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.03.044 – volume: 54 start-page: 49 year: 2009 ident: 10.1016/j.jacc.2018.10.066_bib3 article-title: Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.02.068 – volume: 61 start-page: 1041 year: 2013 ident: 10.1016/j.jacc.2018.10.066_bib19 article-title: Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.10.054 – volume: 5 start-page: 1243 year: 2012 ident: 10.1016/j.jacc.2018.10.066_bib15 article-title: The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography publication-title: J Am Coll Cardiol Img doi: 10.1016/j.jcmg.2012.03.019 – volume: 136 start-page: 1993 year: 2017 ident: 10.1016/j.jacc.2018.10.066_bib31 article-title: Prognostic value of coronary artery calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.030578 – volume: 16 start-page: 1545 year: 1990 ident: 10.1016/j.jacc.2018.10.066_bib24 article-title: Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(90)90298-4 – volume: 21 start-page: 453 year: 2014 ident: 10.1016/j.jacc.2018.10.066_bib27 article-title: Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease publication-title: J Nucl Cardiol doi: 10.1007/s12350-014-9865-9 – volume: 312 start-page: 1754 year: 2014 ident: 10.1016/j.jacc.2018.10.066_bib23 article-title: Nonobstructive coronary artery disease and risk of myocardial infarction publication-title: JAMA doi: 10.1001/jama.2014.14681 – start-page: 39115 year: 2017 ident: 10.1016/j.jacc.2018.10.066_bib29 article-title: Incremental prognostic value of coronary computed tomography angiography: high-risk plaque characteristics in asymptomatic patients publication-title: J Atheroscler Thromb – volume: 136 start-page: 2006 year: 2017 ident: 10.1016/j.jacc.2018.10.066_bib30 article-title: Computed tomography or functional stress testing for the prediction of risk: can i have my cake and eat it? publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.031178 – volume: 18 start-page: 1170 year: 2017 ident: 10.1016/j.jacc.2018.10.066_bib5 article-title: Evaluation of coronary plaque characteristics with coronary computed tomography angiography in patients with non-obstructive coronary artery disease: a long-term follow-up study publication-title: Eur Heart J Cardiovasc Imaging – volume: 3 start-page: 144 year: 2018 ident: 10.1016/j.jacc.2018.10.066_bib21 article-title: Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2017.4973 – volume: 113 start-page: 30 year: 2006 ident: 10.1016/j.jacc.2018.10.066_bib28 article-title: Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.580696 – volume: 11 start-page: 1475 year: 2018 ident: 10.1016/j.jacc.2018.10.066_bib32 article-title: Effects of statins on coronary atherosclerotic plaques: The PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) Study publication-title: J Am Coll Cardiol Img doi: 10.1016/j.jcmg.2018.04.015 – volume: 71 start-page: 363 year: 2007 ident: 10.1016/j.jacc.2018.10.066_bib14 article-title: Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging publication-title: Circ J doi: 10.1253/circj.71.363 – reference: 30678760 - J Am Coll Cardiol. 2019 Jan 29;73(3):302-304. doi: 10.1016/j.jacc.2018.11.017. |
SSID | ssj0006819 |
Score | 2.6833878 |
Snippet | Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.
The purpose of this... AbstractBackgroundUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.... BackgroundUnlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic... Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque.BACKGROUNDUnlike most... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 291 |
SubjectTerms | Aged Angina pectoris Angiography Arteriosclerosis atherosclerotic plaque Calcification Calcification (ectopic) Calcinosis - diagnostic imaging Calcium Cardiology Cardiovascular Cardiovascular disease Clinical trials Computed tomography Computed Tomography Angiography coronary angiography Coronary artery Coronary artery disease Coronary Artery Disease - complications Coronary Artery Disease - diagnostic imaging Coronary Stenosis - etiology Coronary vessels Death Family medical history Female Follow-Up Studies Heart attacks Heart diseases Humans Male Medical imaging Middle Aged Myocardial infarction Myocardial Infarction - etiology Patients Plaque, Atherosclerotic - complications Plaque, Atherosclerotic - diagnostic imaging Statistical analysis Tomography |
Title | Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0735109718392106 https://www.clinicalkey.es/playcontent/1-s2.0-S0735109718392106 https://dx.doi.org/10.1016/j.jacc.2018.10.066 https://www.ncbi.nlm.nih.gov/pubmed/30678759 https://www.proquest.com/docview/2169226803 https://www.proquest.com/docview/2179469381 https://pubmed.ncbi.nlm.nih.gov/PMC6342893 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYoh6qXqu8GKHKl3qqwcZw4zrGNQCskSiVA3ZtrO7YIQgGR7IFLfwu_hV_GTF7qAqJST1HssfyY8XhGnvlMyBdwY1NmnQ7B-gUHJdEu1GVqQu9h2JHxpSsxOfngh5ifJPuLdLFGijEXBsMqB93f6_ROWw8ls2E1Z5dVNTsC4Uzx_rQ741kHu80T2SXxLb5P2ljI7nEPJA6Rekic6WO8zrRFGEMmdzDCq0NKfPRwemh83o-h_OtQ2ntFXg7WJP3WD_g1WXP1G_L8YLgvf0t-FwhQoK-ukcTB5-e5hh5osQrTTEcmuZL-qtpT2j3T3Dh6uGxhYVxDq_r2BkxFelQcHofzXbCCKUYgXr8jJ3u7x8U8HN5UCG0q8zbULiu5iLT10mL6pBYuSXUcoZtlBTOcx85mUeSFy7LMa6M9505KKzOjRWL4e7JeX9TuI6Ex3hl6E5nElknJfW7QweVGyFzIyLOAsHExlR0Ax_Hdi3M1RpadKWSAQgZgGTAgIF-nNpc93MaT1HzkkRoTSUH1KTgNnmyVPdbKNcPubRRTTawi9UDCApJOLVeE9J89bo0CpKZOYiZysH1lxAPyeaqGzY03Nrp2F0ukQfz_HKyqgHzo5W1aFvT1YKPlMJ0VSZwIEDh8taauTjsAccHB6cz5xn9OZ5O8gD8MswvjfIust1dL9wlMs9Zsk2c7f9h2twPvAO8-OQ8 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELYQSG0vFf1PC9SVeqvSTeLEcY4lAi0tC5VY1L25tmOLIBQQyR54mz5Ln6wz-VMXEJV6imSP5dgzHs_IM98Q8hHc2CQ0Vvlg_YKDEivrqyLRvnPw24F2hS0wOXl2xKen8ddFslgj-ZALg2GVve7vdHqrrfuWSb-bk6uynJyAcCb4ftre8SHCbm-ANcBRtA8Wu6M65qKt7oHUPpL3mTNdkNe5MohjGIrPGOLVQiXeezvdtT5vB1H-dSvtb5KnvTlJv3R__Iys2eo5eTTrH8xfkJ85IhSo6xsksfD5fqFgBpqv4jTTgUu2oD_K5oy2dZprS4-XDeyMrWlZ_f4FtiI9yY_n_nQPzGCKIYg3L8np_t48n_p9UQXfJCJrfGXTgvFAGScM5k8qbuNERQH6WYaHmrHImjQIHLdpmjqllWPMCmFEqhWPNXtF1qvLyr4hNMJHQ6cDHZsiLpjLNHq4THORcRG40CPhsJnS9IjjWPjiQg6hZecSGSCRAdgGDPDIp3HMVYe38SA1G3gkh0xS0H0SroMHR6X3jbJ1f3xrGco6koG8I2IeScaRK1L6zxm3BgGS4yRRyDMwfkXAPPJh7IbTjU82qrKXS6TBAgAZmFUeed3J27gt6OzBSctgOSuSOBIgcvhqT1WetQjinIHXmbG3_7mc9-TxdD47lIcHR9_ekSfQgzF3fpRtkfXmemm3wU5r9E57Dv8AXAQ7OA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronary+Artery+Plaque+Characteristics+Associated+With+Adverse+Outcomes+in%C2%A0the+SCOT-HEART+Study&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Williams%2C+Michelle+C.%2C+MBChB%2C+PhD&rft.au=Moss%2C+Alastair+J.%2C+MD&rft.au=Dweck%2C+Marc%2C+MBChB%2C+PhD&rft.au=Adamson%2C+Philip+D.%2C+MD%2C+PhD&rft.date=2019-01-29&rft.issn=0735-1097&rft.volume=73&rft.issue=3&rft.spage=291&rft.epage=301&rft_id=info:doi/10.1016%2Fj.jacc.2018.10.066&rft.externalDBID=ECK1-s2.0-S0735109718392106&rft.externalDocID=1_s2_0_S0735109718392106 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109718X00096%2Fcov150h.gif |